Anti-Mullerian Hormone as a New Marker for Diagnosis of Polycystic Ovary Syndrome

    Abdel Monieum Mohamed Zakaria, Ahmed Osama, Ahmed Kamal Mohamed Abo Sheashea
    Studysummary This study found that anti-Müllerian hormone (AMH) showed high sensitivity and specificity as a diagnostic marker for polycystic ovary syndrome in the studied population, suggesting its promise as an objective diagnostic tool.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ejhm.journals.ekb.eg →
    Discuss this study in the Community →

    Related research 3

    1. Reconsidering PCOS Etiology, Diagnosis, Clinical Subgroups, and Subgroup-Specific Treatments Endocrine and metabolic science · 2024
    2. Polycystic Ovarian Syndrome: Current Understanding of Pathogenesis, Diagnosis, and Treatment Meditsinskiy sovet = Medical Council · 2021
    3. Screening for Diabetes in Women with Polycystic Ovary Syndrome Canadian Medical Association Journal · 2007